Literature DB >> 7042540

In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.

R Arnon, M Sela.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042540     DOI: 10.1111/j.1600-065x.1982.tb00387.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  16 in total

Review 1.  Molecular recognition in antibodies and its application.

Authors:  M C Tedford; W H Stimson
Journal:  Experientia       Date:  1991-12-01

2.  Antigen-specific drug-targeting used to manipulate an immune response in vivo.

Authors:  M M Abu-hadid; R B Bankert; G L Mayers
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Doxorubicin conjugates of monoclonal antibodies to hepatoma-associated antigens.

Authors:  D Shouval; R Adler; J R Wands; E Hurwitz; K J Isselbacher; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Effects of methotrexate-carcinoembryonic-antigen-antibody immunoconjugates on GW-39 human tumors in nude mice.

Authors:  L B Shih; D M Goldenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Preparation of AHTG-DNR conjugates and their antitumor effect in vitro.

Authors:  D H Zhang; J Z Tang; G X Shen; N Shu; H F Zhu
Journal:  J Tongji Med Univ       Date:  1990

6.  Inhibition of Epstein-Barr-virus-transformed human chronic lymphocytic leukaemic B cells with monoclonal-antibody-adriamycin (doxorubicin) conjugates.

Authors:  Z Zhu; J Kralovec; T Ghose; M Mammen
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

7.  The role of monoclonal antibody A7 as a drug modifier in cancer therapy.

Authors:  K Kitamura; T Miyagaki; N Yamaoka; H Tsurumi; A Noguchi; T Yamaguchi; T Takahashi
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

8.  Synthesis and characterization of a ribavirin-3',5'-phosphate pentadecamer homoribopolymer bearing a 5'-amino tether group and a 3'-thymidine.

Authors:  M I Dawson; A N Jina; S Torkelson; S Rhee; M Moore; D A Zarling; P D Hobbs
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

9.  The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin.

Authors:  C F Scott; V S Goldmacher; J M Lambert; R V Chari; S Bolender; M N Gauthier; W A Blättler
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies.

Authors:  Y Tsukada; E Hurwitz; R Kashi; M Sela; N Hibi; A Hara; H Hirai
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.